Compositions and methods involving methyladenosine phosphorylase in the diagnosis and treatment of proliferative disorders
作者： Olufunmilayo I. Olopade
DOI:
关键词:
摘要: Disclosed are novel nucleic acid and peptide compositions comprising methylthioadenosine phosphorylase (MTAP) methods of use for MTAP amino sequences DNA segments in the diagnosis human cancers development MTAP-specific antibodies. Also disclosed treatment tumors other proliferative cell disorders, identification tumor suppressor genes gene products from 9p21-p22 chromosome region. Such useful multiple types such as bladder cancer, lung breast pancreatic brain tumors, lymphomas, gliomas, melanomas, leukemias.
osti.gov
lens.org 参考文章(41)
N Kamatani, AL Yu, DA Carson, Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo Blood. ,vol. 60, pp. 1387- 1391 ,(1982) , 10.1182/BLOOD.V60.6.1387.1387
J Hebert, JM Cayuela, J Berkeley, F Sigaux, Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood. ,vol. 84, pp. 4038- 4044 ,(1994) , 10.1182/BLOOD.V84.12.4038.BLOODJOURNAL84124038
Naoyuki Kamatani, Masaru Kubota, Erik H. Willis, Lee A. Frincke, Dennis A. Carson, 5′-Methylthioadenosine is the Major Source of Adenine in Human Cells Advances in Experimental Medicine and Biology. pp. 83- 88 ,(1984) , 10.1007/978-1-4757-0390-0_18
Naoyuki Kamatani, Masaru Kubota, Erik H. Willis, Dennis A. Carson, 5′-Methylthioadenosine Phosphorylase Deficiency in Malignant Cells: Recessive Expression of the Defective Phenotype in Intra-Species (Mouse X Mouse) Hybrids Advances in Experimental Medicine and Biology. pp. 279- 283 ,(1984) , 10.1007/978-1-4757-0390-0_53
D. A. Carson, T. Nobori, T. A. Waltz, F. Della Ragione, J. G. Karras, P. P. Chen, Absence of Methylthioadenosine Phosphorylase in Human Gliomas Cancer Research. ,vol. 51, pp. 3193- 3197 ,(1991)
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Tetsuro Nishihira, Shozo Mori, Koh Miura, Yusuke Nakamura, Takahisa Aoki, Takahiro Mori, Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Research. ,vol. 54, pp. 3396- 3397 ,(1994)
B Quesnel, C Preudhomme, N Philippe, M Vanrumbeke, I Dervite, JL Lai, F Bauters, E Wattel, P Fenaux, p16 gene homozygous deletions in acute lymphoblastic leukemia Blood. ,vol. 85, pp. 657- 663 ,(1995) , 10.1182/BLOOD.V85.3.657.BLOODJOURNAL853657
F Della Ragione, A Oliva, V Gragnaniello, G L Russo, R Palumbo, V Zappia, Physicochemical and immunological studies on mammalian 5'-deoxy-5'-methylthioadenosine phosphorylase. Journal of Biological Chemistry. ,vol. 265, pp. 6241- 6246 ,(1990) , 10.1016/S0021-9258(19)39316-0
Dennis A. Carson, Naoyuki Kamatani, Abnormal Regulation of Methylthioadenosine and Polyamine Metabolism in Methylthioadenosine Phosphorylase-deficient Human Leukemic Cell Lines Cancer Research. ,vol. 40, pp. 4178- 4182 ,(1980)